Cannabidiol is under clinical development by Jazz Pharmaceuticals and currently in Phase II for Rett Syndrome.

Eva Rizzo is able to gain a sense of independence when she partners with her horse at Sebastian Riding Associates in Collegeville.

Long-term clinical profiles of female patients with classic Rett syndrome are presented and exemplified by three cases, as experienced over four decades. Emphasized is the frequently surprisingly ...

Fintel reports that on January 3, 2025, Guggenheim downgraded their outlook for ACADIA Pharmaceuticals (NasdaqGS:ACAD) from ...

Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on ...

Neurogene has halted patient enrolment in the high-dose arm of its trial of Rett syndrome gene therapy, sparking another run on its shares. Last week, the company reported that NGN-401 had shown ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Scientists just discovered that a common cat parasite might be the key to treating brain disorders. Here's how this weird breakthrough could change ev ...

Acadia’s 50-day moving average is in the process of crossing above the stock’s 200-day moving average. This crossover forms a ...

Differences showed up ... Developmental Disorder Discovery Could Lead to Better Treatments for Rett Syndrome Dec. 19, 2024 — New discoveries about the severe developmental disorder known as Rett ...